Computational Antibody Discovery: State of the Art

Recent advances in computational and machine learning sciences have had a substantial impact on the antibody discovery process. Novel protocols that incorporate computational approaches can now be used to generate functional antibody therapeutics with good developability. In silico methods complement existing experimental strategies, and their use has become more mainstream in the biopharmaceutical industry. However, the application of computational de novo design strategies requires a thorough understanding of their capabilities, limitations, and experimental validation, as well as their place in the overall discovery pipeline and value chain.

In this virtual Symposium, leading experts in computational antibody discovery from academia and industry discuss their scientific strategies and progress to date. The event aims to provide a platform for better understanding of the breakthroughs and future directions in this multidisciplinary field, through talks, a panel session, and your questions and insights. The Symposium begins with speakers Drs. Pietro Sormanni, Tzvika Hartman Victor Greiff, Sandeep Kumar, and Ben Holland. The panel session, moderated by Dr. Konrad Krawczyk, includes Drs. Jiye Shi and Sandeep Kumar, Victor Greiff, and Ben Holland. 

Seminar Information
Date Presented:
June 22, 2023 11:00 AM Eastern
Length:
4 hours
Register Now
In order to access this program after registering, a TAS account will be provided for you based on the information you have entered.

To access your account after your purchase, use the My Account links on the left hand side of this page to login using the information your provide here.
According to our records there is already a TAS account using the email address you have provided.

To continue with your registration please enter your account password. If you do not know your account password you can retrieve it here: Forgot Password?
First Name:
Last Name:
Email:
Confirm Email:
Organization:
Job Title:
State/Province:
Country:
Product:
On-Demand
The email address you have entered has an existing TAS account.

Please enter your password in the field below. Forgot Password?

Email:
Password:
Country:
Billing Address:
City:
State:
State/Province:
Zip:
Expiration: 
Computational Antibody Discovery: State of the Art (Part 1)

Recent advances in computational and machine learning sciences have had a substantial impact on the antibody discovery process. Novel protocols that incorporate computational approaches can now be used to generate functional antibody therapeutics with good developability. In silico methods complement existing experimental strategies, and their use has become more mainstream in the biopharmaceutical industry. However, the application of computational de novo design strategies requires a thorough understanding of their capabilities, limitations, and experimental validation, as well as their place in the overall discovery pipeline and value chain.

In this virtual Symposium, leading experts in computational antibody discovery from academia and industry discuss their scientific strategies and progress to date. The event aims to provide a platform for better understanding of the breakthroughs and future directions in this multidisciplinary field, through talks, a panel session, and your questions and insights. The Symposium begins with speakers Drs. Pietro Sormanni, Tzvika Hartman Victor Greiff, Sandeep Kumar, and Ben Holland. The panel session, moderated by Dr. Konrad Krawczyk, includes Drs. Jiye Shi and Sandeep Kumar, Victor Greiff, and Ben Holland. 

Speaker Information
Victor Greiff  [ view bio ]
Tzvika Hartman  [ view bio ]
Ben Holland  [ view bio ]
Sandeep Kumar  [ view bio ]
Pietro Sormanni  [ view bio ]
Computational Antibody Discovery: State of the Art (Part 2)
Computational Antibody Discovery: State of the Art (Part 3)
Individual topic purchase: Selected